SEC Form 4 · accession 0000899243-16-017853
SOLENO THERAPEUTICS INC · SLNO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bhatnagar Anish
Officer — President and CEO · Director
Period of report
Apr 8, 2016
Accepted (ET)
Apr 11, 2016 · 6:10 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001484565
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 8, 2016 | M | 58,419 | $1.20 | A | 58,419 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option | $1.20 | Apr 8, 2016 | M | 58,419 | D | Jun 1, 2014 | Jun 3, 2020 | Common Stock | 58,419 | 0 | D |